What is USANA Health Sciences's SG&A?

USANA Health Sciences (USNA) reported SG&A of $88.25M in Q1 2026.

How has USANA Health Sciences's SG&A changed year-over-year?

USANA Health Sciences's SG&A decreased by 3.5% year-over-year, from $91.44M to $88.25M.

What is the long-term trend for USANA Health Sciences's SG&A?

Over 3 years (2022 to 2025), USANA Health Sciences's SG&A has grown at a 8.8% compound annual growth rate (CAGR), from $262.3M to $337.37M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

USANA Health Sciences USNA SG&A

Discontinued — last reported Q1 '26

SG&A at other companies

Nature's Sunshine ProductsNATR

$43.54M+7.3%

BellRing BrandsBRBR

$91.5M+1.1%

US FoodsUSFD

$1.43B+3.2%

Universal CorporationUVV

$72.37M-1.2%

Archer Daniels MidlandADM

$961M+3.1%

AbbottABT

$3.74B+22.2%

Segments

By segment

See full

Core Nutritional$60.75M—

Hiya$24.77M+5.4%

Rise$2.74M—

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$363.35M-36.1%

P/E18.1×+7.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USANA Health Sciences's SG&A?: USANA Health Sciences (USNA) reported SG&A of $88.25M in Q1 2026.
How has USANA Health Sciences's SG&A changed year-over-year?: USANA Health Sciences's SG&A decreased by 3.5% year-over-year, from $91.44M to $88.25M.
What is the long-term trend for USANA Health Sciences's SG&A?: Over 3 years (2022 to 2025), USANA Health Sciences's SG&A has grown at a 8.8% compound annual growth rate (CAGR), from $262.3M to $337.37M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.